Results 171 to 180 of about 1,366,092 (327)

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Whole-Genome Allelotyping Identified Distinct Loss-of-Heterozygosity Patterns in Mucinous Ovarian and Appendiceal Carcinomas [PDF]

, 2005
Colleen M. Feltmate, Kenneth R. Lee, Michael E. Johnson, John O. Schorge, Kwong‐Kwok Wong, Ke Hao, William R. Welch, Debra A. Bell, Ross S. Berkowitz, Samuel C. Mok   +9 more
openalex   +1 more source

Ligand‐Based CAR‐T Cells Targeting EGFR Exhibit Favorable Antitumor Effects Against Gynecologic Malignancies

Cancer Science, EarlyView.
Wide variety of gynecologic malignancies express EGFR at high rates. Memory‐rich EGFR CAR‐T cells can be made by piggyBac‐mediated gene transfer with immature dendritic cells and EGFR protein. Ligand‐based EGFR CAR‐T cells have robust antitumor effects against gynecologic malignancies in vivo and in vitro.
Manaka Shinagawa, Koichi Hirabayashi, Marina Fujioka, Kyosuke Kamijo, Natsuki Uchiyama, Yusuke Yokokawa, Yasuhiro Tanaka, Motoki Ono, Thanyavi Chinsuwan, Ryoichi Asaka, Aiko Hasegawa, Miyuki Tanaka, Takashi Murakami, Shigeki Yagyu, Tsutomu Miyamoto, Tanri Shiozawa, Yozo Nakazawa   +16 more
wiley   +1 more source

Mucinous carcinoma of the breast: Rare histological entity to know: About two cases and review of literature. [PDF]

Int J Surg Case Rep, 2023
Bencherifi Y, Watik F, Lyafi Y, Mostapha B, Ennachit M, Mohammed EK.   +5 more
europepmc   +1 more source

A Case of Carbohydrate Antigen 19-9 Producing Gastric Mucinous Carcinoma.

, 2001
Kiyomi Shiota, Takanori UEKI, Atsushi Shiozaki, Shigeyoshi Aoi, Jiro Hirai, Keisuke NAKAJI, Takumi Miyauchi   +6 more
openalex   +2 more sources

Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women

Clinical Endocrinology, EarlyView.
ABSTRACT Context Androgen excess is common in women and refers to clinical or biochemical evidence of elevated androgenic steroids such as testosterone. It is associated with underlying polycystic ovary syndrome in the majority of cases. However severe androgen excess is less common and may indicate the presence of underlying adrenal or ovarian ...
Yasir S. Elhassan, James M. Hawley, Leanne Cussen, Ali Abbara, Sophie A. Clarke, Punith Kempegowda, Rima K. Dhillon‐Smith, Puja Thadani, Maureen Busby, Lucy Owusu‐Darkwah, Rachel Marrington, W. Colin Duncan, Robert K. Semple, Richard Quinton, Michael W. O'Reilly   +14 more
wiley   +1 more source

Coexisting Tuberculosis And Mucinous Carcinoma Of Caecum – A Case Report [PDF]

, 2005
Sushama R. Desai, Sunil Vitthalrao Jagtap, Hemant B. Janugade   +2 more
openalex   +1 more source

Bilateral Primary Mucinous Carcinoma of the Eyelid.

Ophthalmic Plastic and Reconstructive Surgery, 2017
C. Burris, Meisha L. Raven, M. Rodríguez, H. Potter, M. Lucarelli, D. Albert   +5 more
semanticscholar   +1 more source

WHO Reporting System for Lung Cytopathology: Insights Into the Insufficient/Inadequate/Non‐Diagnostic, Atypical and Suspicious for Malignancy Categories and How to Use Them

Cytopathology, EarlyView.
The WHO System is an international effort to standardise category definitions, establish the key diagnostic cytopathological features of entities of the lung, propose the best use of ancillary tests in lung specimens, encourage the use of standardised pathology reports containing essential components in an integrated report and propose estimates of the
Zahra Maleki, Sule Canberk, Andrew Field
wiley   +1 more source

Race as a prognostic factor of breast mucinous carcinoma. [PDF]

J Cancer Res Clin Oncol
Wang D, Wang Y, Gao S, Zheng R, Wu G, Wang J, Lu C, Bu K, Zhang C, Chen W, Zhang B.   +10 more
europepmc   +1 more source